Taro Pharmaceuticals U.S.A., Inc. recalls Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Br…
- Recall date
- March 17, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0790-2017
- FDA classification
- Class III
- Brand / firm
- Taro Pharmaceuticals U.S.A., Inc.
- Sold / distributed
- U.S. Nationwide
Why it was recalled
Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1254-3
Get recall alerts
Free email alert whenever Taro Pharmaceuticals U.S.A., Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Taro Pharmaceuticals U.S.A., Inc.